InvestorsHub Logo
icon url

Zues

04/07/17 6:40 PM

#49012 RE: BearRickPunch #49008

Nice post. From my perspective, when we consider that USRM released a PR stating that the FDA asked for more information makes me think that they intend to release the RMAT FDA decision soon after receipt. Also, I believe rather strongly that USRM is extremely confident (not just hopeful) in obtaining RMAT designation, otherwise they would not have made it public that the FDA wanted more info. The USRM PR was more than an update, it was a signal. JMO
icon url

Kramden1

04/08/17 8:32 AM

#49139 RE: BearRickPunch #49008

I disagree with the statement that "USRM has been very quiet regarding any news with FDA"

How can 1 claim "very quiet" when they let investors know USRM felt that Myocell fit the bill for approval before they applied. USRM was letting us know they would be applying before they applied? They also allowed us via a blog to inform us that THEY did apply! USRM has clearly stated that the FDA had received the application, and requested more information! I don't see what you're looking for in the form of communication from IR! Not trying to be argumentative, I just view it differently I guess. I'm long here myself bud, and GLTA! ;)